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Although oxytocin (OT) has become a major target for the investigation of positive
social processes, it can be assumed that it exerts its effects in concert with other
neurotransmitters. One candidate for such an interaction is dopamine (DA). For both
systems, genetic variants have been identified that influence the availability of the
particular substance. A variant of the gene coding for the transmembrane protein CD38
(rs3796863), which is engaged in OT secretion, has been associated with OT plasma level.
The common catechol-O-methyltransferase (COMT) val158met polymorphism is known to
influence COMT activity and therefore the degradation of DA. The present study aimed
to investigate OT × DA interactions in the context of an OT challenge study. Hence,
we tested the influence of the above mentioned genetic variants and their interaction
on the activation of different brain regions (amygdala, VTA, ventral striatum and fusiform
gyrus) during the presentation of social stimuli. In a pharmacological cross-over design
55 participants were investigated under OT and placebo (PLA) by means of fMRI. Brain
imaging results revealed no significant effects for VTA or ventral striatum. Regarding
the fusiform gyrus, we could not find any effects apart from those already described in
Sauer et al. (2012). Analyses of amygdala activation resulted in no gene main effect, no
gene × substance interaction but a significant gene × gene × substance interaction.
While under PLA the effect of CD38 on bilateral amygdala activation to social stimuli was
modulated by the COMT genotype, no such epistasis effect was found under OT. Our
results provide evidence for an OT × DA interaction during responses to social stimuli. We
postulate that the effect of central OT secretion on amygdala response is modulated by
the availability of DA. Therefore, for an understanding of the effect of social hormones on
social behavior, interactions of OT with other transmitter systems have to be taken into
account.
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INTRODUCTION
In social neuroscience, the neuropeptide oxytocin (OT) has
become a major target for the investigation of positive social pro-
cesses (Meyer-Lindenberg et al., 2011). However, although it can
be shown that OT enhances positive social behavior (Yamasue
et al., 2012), it must be assumed that the neuropeptide exerts its
effects in concert with other neurotransmitters. One of the main
candidates for such an interaction is dopamine (DA) (Skuse and
Gallagher, 2009). Interactions between the OT and the DA sys-
tem have been investigated for a longer time in animal research,
mainly in the context of bonding and sexual behavior (Liu and
Wang, 2003). While OT is strongly involved in establishing pair
bonding, DA is thought to make mating a rewarding experience
(Young and Wang, 2004).
Interconnections between both systems on the molecular und
structural level probably build the fundament for these behavioral
effects. DA receptors can be found on OT neurons in various
brain regions particularly in the nuclei of the hypothalamus,
where the OT system has its seeds (Baskerville et al., 2009).
Furthermore, OT and DA receptors are collocated in regions of
the mesolimbic DA system (Insel and Shapiro, 1992) and the
injection of OT in a core region of this system, the ventral tegmen-
tal area (VTA) increases DA release in the nucleus accumbens,
another core region of the mesolimbic DA system which receives
projections from the VTA (Melis et al., 2007). Very recently the
existence of D2-OT-receptor heteromers in the rat striatum has
been proposed which might constitute a molecular mechanism
underlying these OT-DA interactions (Romero-Fernandez et al.,
2012).
In contrast to this extended animal literature on the interplay
between OT and DA, much less is known about these interactions
in humans. Very recently Love and colleagues found an effect of a
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common gene polymorphism (rs4813625) on the oxytocin recep-
tor gene (OXTR) on the dopaminergic response to stress (Love
et al., 2012). In a [11C] raclopride positron emission tomogra-
phy study, they found an increased DA release in the ventromedial
caudate during pain induced stress in female but not male carriers
of the rs4813625 C-allele. They interpret their result as reflect-
ing the impact of the oxytocin receptor on stress induced DA
release.
In human neuroimaging research, the impact of OT on brain
functions has mainly been investigated in OT challenge stud-
ies looking on the effect of intranasal OT application on neu-
robiological correlates of social cognitive processes (Zink and
Meyer-Lindenberg, 2012). The most robust result is an attenua-
tion of amygdala activation to social stimuli under OT compared
to placebo, which was already demonstrated in our first study
on that issue (Kirsch et al., 2005) and which could be replicated
in several studies using different stimulation paradigms (e.g.,
Domes et al., 2007; Baumgartner et al., 2008; Petrovic et al., 2008).
However, the amygdala is not only a mediator of OT effects,
but is also an important target of the DA system. In humans, a
modulatory effect of DA on amygdala activity during process-
ing of negative emotional pictures (Kienast et al., 2008) and faces
(Tessitore et al., 2002) has been shown. Furthermore, dopamin-
ergic neurons in the central amygdala are activated during fear
learning (Guarraci et al., 1999), potentially by a DA mediated
attenuation of inhibitory signaling in the amygdala (Naylor et al.,
2010). The amygdala might therefore also be an interesting region
of interest (ROI) for the investigation of OT-DA interactions.
Interestingly, paralleling their former results on OT injection in
the VTA (Melis et al., 2007), Melis and colleagues also found an
increase of mesolimbic DA release after OT injection into the
amygdala (Melis et al., 2009).
To investigate OT × DA interactions in humans, an appropri-
ate approach could be to look for epistasis effects between genetic
variants that influence one or both of the systems. For both sys-
tems, OT and DA, functional genetic variants have been identified
that influence the secretion or availability of the particular sub-
stance. For the OT system, the transmembrane protein CD38 has
recently gained lots of attention. Although CD38 is expressed
on different types of cells and is mainly known for its role in
the immune system, it was recently found to play an impor-
tant role in central OT secretion and to modulate social behavior
(Jin et al., 2007). Importantly, the effect of CD38 on transmitter
secretion was found to be specific to OT while the secretion of
other transmitters, like striatal DA, or hypothalamic vasopressin
was not affected. CD38 knockout mice show reduced OT lev-
els and impaired social behavior. In humans, a common single
nucleotide polymorphism (SNP) has been identified on the CD38
gene (rs3796863) that is associated with reduced CD38 expression
in lymphoblasts (Lerer et al., 2010), reduced OT plasma levels and
parental touch (Feldman et al., 2012) and also with autism spec-
trum disorder, a condition associated with severe social deficits
(Lerer et al., 2010; Munesue et al., 2010). The presence of the
C allele which was found to be associated with autism results
in a reduced CD38 expression. Furthermore, we could recently
show that this genetic variant also modulates the brain response
to social stimuli in the fusiform gyrus, an important node of the
social brain (Sauer et al., 2012). Here, the C allele was associated
with stronger activation of the fusiform area.
For DA, the enzyme catechol-O-methyltransferase (COMT)
is involved in the extraneuronal degradation of the transmitter
and therefore influences its availability in the brain. A common
variant on the gene coding for the enzyme, the val158met SNP
(rs4860), is known to strongly influence the enzymatic activity
of COMT (Chen et al., 2004). Carriers of the met allele show
reduced enzymatic activity and therefore reduced degradation
of the transmitter. On the brain level, this genetic variant has
been shown to modulate brain responses during both, executive
cognition and emotional processing paradigms and there is evi-
dence for a pleiotropic action of the gene with the met allele
favoring executive cognition and the val allele favoring emo-
tional processing (Mier et al., 2010). Goldman and colleagues
postulate a warrier/worrier dichotomy with the val allele sup-
porting a stress resistant but slightly cognitively restricted and
the met allele a cognitively superior but affectively more labile
phenotype (Goldman et al., 2005). This dichotomy explaining
the persistence of both alleles is supported by data demonstrat-
ing increased pain stress tolerance in val allele and an increased
affective response to pain in met allele carriers (Zubieta et al.,
2003). Interestingly, very recently this model was further sup-
ported by data showing that the superiority of met allele carriers
in executive cognitive functions is diminished under social stress
(Buckert et al., 2012).
While an impact of the CD38 gene polymorphism rs3796863
on amygdala could not be demonstrated so far (Sauer et al., 2012),
a number of studies investigated effects of the COMT geno-
type on amygdala responses (Smolka et al., 2005, 2007; Drabant
et al., 2006; Domschke et al., 2008, 2012; Kempton et al., 2009;
Rasch et al., 2010; Williams et al., 2010; Lelli-Chiesa et al., 2011;
Lonsdorf et al., 2011). However, these studies produced very
inconsistent results ranging from no effect of rs4860, increased
activation in val allele carriers or in met allele carriers to geno-
type × gender interactions. Therefore, it can be assumed that the
effect of the particular genetic variant is modulated by other genes
in terms of epistasis effects. Given an OT-DA interaction, the
effect of the COMT genotype could be modulated by the CD38
genotype.
This study was conducted to explore COMT×CD38 genotype
interactions in the human brain. Therefore, we further analyzed
the data from our recently published OT challenge study (Sauer
et al., 2012). Within this dataset, we investigated the influence of
the polymorphisms rs379686 and rs4860 and their interaction on
four different brain regions during the presentation of socially
relevant stimuli. First, we focused on the amygdala because of
its central role in human OT research and the heterogeneous
results for COMT genotype. Second, given the results from ani-
mal research, we were interested in dopaminergic structures like
the VTA and the ventral striatum. Third, for the sake of com-
pleteness, we also included the fusiform gyrus since it was mainly
influenced by CD38 genotype in our previous study (Sauer et al.,
2012). Furthermore, to test the impact of exogenous OT on
potential genetic effects, we applied a pharmacological cross-
over design where participants were investigated under OT and
placebo (PLA).
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MATERIALS AND METHODS
PARTICIPANTS
The sample was already described elsewhere (Sauer et al., 2012).
It consists of 55 healthy young men of European ancestry (M =
24.9 ± 2.6 years). Only participants with no history of psychiatric
or neurological diseases were included. All had at least 12 years of
education, were non-smokers or smoked only occasionally and,
except for one, all were right-handed. With respect to the CD38
SNP (rs3796863), 30 were homozygotic carriers of the C allele
(CC), 23 were heterozygotes (CA) and 2 were homozygotic car-
riers of the A allele (AA). For subsequent statistical analyses, we
pooled together AA and CA genotypes (A+) and compared them
to the CC carriers (A−). Recent studies revealed the A− vari-
ant being associated with lower plasma OT levels and a higher
risk for autism-spectrum-disorders compared to the A+ vari-
ant (Lerer et al., 2010; Munesue et al., 2010; Feldman et al.,
2012).
With respect to the COMT val158met SNP (rs4680), 11 sub-
jects were homozygotic carriers of the met allele (met/met), 31
were heterozygotes (val/met) and 13 were homozygotic carri-
ers of the val allele (val/val) which has been shown to lead to a
higher COMT activity and lower DA levels in prefrontal cortex
(Chen et al., 2004). The distribution of genotype combinations
is presented in Table 1. All genotype distributions are in Hardy-
Weinberg-Equilibrium (COMT Val158Met: Chi2 = 0.91, df = 1,
n.s.; CD38 (rs3796863): Chi2 = 0.91, df = 1, n. s.).
Between the groups, there were no differences in age, educa-
tion or order of substance application (all p > 0.1).
The study was approved by the ethics board of the German
Psychological Society (DGPs) and all participants gave written
informed consent.
EXPERIMENTAL DESIGN AND PROCEDURE
The experimental design and procedures are described in detail
elsewhere (Sauer et al., 2012). We performed a double-blind
placebo-controlled cross-over study. All participants attended two
fMRI sessions at intervals of 1 week. They were instructed to
abstain from alcohol and nicotine for 12 h before the session and
from caffeine for 3 h. In each session, participants administered
themselves either placebo or a dose of 25 IU of OT (Syntocinon
Spray, Novartis, Austria; 5 puffs alternating nostrils, each with
5 IU) intranasally under the supervision of the investigator. To
reach a sufficient and stable level of the substance in the brain
(Born et al., 2002), the application took place about 30min prior
to the start of the fMRI experiment. In the meantime, participants
Table 1 | Distribution of CD38 and COMT genotypes in the sample.
COMT Total
(val158met polymorphism)
val/val val/met met/met
CD38 (rs3796863) A+ 5 14 6 25
A− 8 17 5 30
Total 13 31 11 55
completed several questionnaires to control for substance effects
on different variables like mood, arousal etc.
EachMRI session consisted of a 5min anatomical scan and two
different fMRI paradigms. The anatomical scan was performed
during the last 5min of the 30min time gap between substance
application and the first fMRI experiment. Both fMRI experi-
ments were designed to investigate aspects of social cognition.
The first one was an extended version of the Hariri face match-
ing task which is known to robustly activate the amygdala and
other parts of the social brain (Hariri et al., 2002a,b, 2003). The
task is implemented as a block design and requires subjects to
match one of two presented stimuli to a simultaneously presented
target stimulus. In the extended version we had five different
conditions which were repeatedly presented in a non-randomized
order. Four conditions consisted of pictures of emotional faces
from the Pictures of Facial Affect series (Ekman and Friesen,
1976), or socially relevant scenes from the International Affective
Picture System (Lang et al., 2008) with either positive or nega-
tive valence. In addition, geometrical shapes were presented in a
control condition. Each social emotional condition was presented
four times in 30 s blocks consisting of six trials per block. After
each social emotional condition, the control condition was pre-
sented in 15 s blocks à six trials. The second fMRI paradigm was
on gaze processing. However, as we do not further refer to this
paradigm here, we won’t describe it in detail.
fMRI DATA ACQUISITION
fMRI data were acquired on a 3T Siemens TRIO scanner (Siemens
Medical Systems, Erlangen, Germany) with the following param-
eters for the functional MRI scans using EPI sequences: 30 axial
slices à 4mm, 1mm gap, TR = 2 s, TE = 30ms, FoV 192 ×
192mm, flip angle 80◦. Anatomical data were obtained from a
T1 weighted three dimensional MPRAGE sequence (192 sagit-
tal slices of 1mm thickness, TR = 2.3 s, TE = 3.03ms, FoV
256 × 256mm, flip angle 9◦).
fMRI DATA ANALYSIS
fMRI data were analyzed using SPM8 (http://www.fil.ion.ucl.ac.
uk/spm). Preprocessing procedures included realignment to the
first image, slice-time correction, spatial normalization into a
standard stereotactic space with a voxel size of 2 × 2 × 2mm
using the Montreal Neurological Institute (MNI) template and
smoothing with an 8mm full width at half maximum (FWHM)
Gaussian kernel.
After preprocessing, a general linear model (GLM) incorporat-
ing both substance conditions (PLA, OT) as separate sessions was
applied for each subject. For each session, five task regressors (one
for each experimental condition) and six motion parameters were
included. On the first level we specified contrasts for both sub-
stance conditions separately (OT, PLA) and for the comparison
between substances (OT vs. PLA).
Since we were interested in general aspects of social vs. non-
social processing, we defined a contrast comparing all social
stimuli to the control stimuli (contrast “social > non-social”).
We also defined contrasts comparing each social condition sep-
arately to the control condition (“negative faces > non-social”,
“positive faces > non-social”, “negative scenes > non-social”,
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“positive scenes> non-social”). However, these contrasts did not
reveal any additional aspects but the same results as the combined
contrast. Therefore, we decided to only report results for the com-
bined contrast since the single contrasts have a lower power to
detect subtle gene effects and show only marginally significant
results.
Finally, we defined an interaction contrast by combining the
task conditions with the substance conditions (social—non-social
condition under PLA> social—non-social condition under OT).
On the second level, we performed multiple regression anal-
yses for each first level contrast using the information of both
polymorphisms independently and their interaction term as
regressors. We also added substance order as a covariate of
no interest to control for potential influences. To particularly
address genetic effects on amygdala, VTA, ventral striatum and
fusiform gyrus, we conducted ROI analyses. For the amygdala
and the fusiform gyrus, we used anatomically defined Anatomical
Automatic Labeling (AAL) masks provided by the Wake Forest
University (WFU) PickAtlas software (http://fmri.wfubmc.edu).
Masks for VTA and ventral striatum were created with the
MARINA software tool (Walter et al., 2003). For each ROI analysis
independently, we applied a significance level of p < 0.05 cor-
rected for multiple comparisons using Family Wise Error (FWE)
correction and an additional cluster size threshold of k = 10
contiguously activated voxels.
To further explore results from CD38 × COMT genotype ×
substance interactions on amygdala activation in detail, we first
identified the peak voxel from the CD38 × COMT interaction
effect on the contrast (social—non-social condition under PLA
> social—non-social condition under OT) for left and right
amygdala separately. We then extracted mean parameter estimates
from that voxels + 5mm sphere for the PLA and OT condi-
tions separately. Afterwards, we further analyzed these data using
GLM repeatedmeasures procedures implemented in IBM SPSS 20
(IBM Inc., Armonk, NY.). Models consisted of valence (positive
vs. negative) and substance condition (OT vs. PLA) as within-
subject factors, CD38 and COMT genotypes as between-subject
factors and substance order as a covariate of no interest.
ANALYSIS OF BEHAVIORAL DATA
For the analysis of behavioral effects, we analyzed the median of
the response time (RT) for each condition. To control for baseline
effects, we then computed differences between the social and the
non-social conditions for both valences separately. These differ-
ence RTs were then incorporated into a GLM by means of IBM
SPSS 20. Paralleling the analyses of amygdala activation, the GLM
comprised valence and substance as within-subject factors, CD38
and COMT genotype as between-subject factors and substance
order as covariate of no interest.
GENOTYPING PROCEDURES
DNAwas extracted from buccal cells to avoid a selective exclusion
of subjects with blood and injection phobia. Automated purifica-
tion of genomic DNA was conducted by means of the MagNA
Pure® LC system using a commercial extraction kit (MagNA Pure
LC DNA isolation kit; Roche Diagnostics, Mannheim, Germany).
Genotyping was performed by real time-polymerase chain
reaction (RT-PCR) using fluorescence melting curve detection
analysis by means of the Light Cycler System (Roche Diagnostics,
Mannheim, Germany). The primers and hybridization probes
used (TIB MOLBIOL, Berlin, Germany) were as follows:
For CD38: forward primer: 5′-ACACTGAAGAAACTTGT
CAGGTCTA-3′; reverse primer: 5′-CTTGGTTGCTGCTCC
TACTGTT-3′; sensor hybridization probe: 5′-TTTGACCATCAG
GTGGCA–FL -fluorescein-3′: anchor hybridization probe:
5′-LCRed640-GGATAGCTCCCCTCCCGACA-phosphate-3′.
For COMT: forward primer: 5′-GGGCCTACTGTGGCT
ACTCA-3′; reverse primer: 5′-GGCCCTTTTTCCAGGTCTG-3′;
anchor hybridization probe: 5′-LCRed640-TGTGCATGCCTGA
CCCGTTGTCA-phosphate-3′; sensor hybridization probe: 5′-AT
TTCGCTGGCATGAAGGACAAG -fluorescein-3′.
PCR runs comprised 55 cycles of denaturation (95◦C, 0 s,
ramp rate 20◦C s-1), annealing (57◦C, 10 s, ramp rate 20◦C s-1)
and extension (72◦C, 10 s, ramp rate 20◦C s-1) which followed
an incubation period of 10min to activate the FastStart Taq
DNA Polymerase of the reaction mix (Light Cycler FastStart DNA
Master Hybridization Probes, Roche Diagnostics, Mannheim,
Germany). After amplification a melting curve was generated by
holding the reaction time at 40◦C for 2min and then heating
slowly to 95◦Cwith a ramp rate of 0.2◦C s-1. The fluorescence sig-
nal was plotted against temperature to yield the respective melting
points (Tm) of the two alleles for both SNPs respectively. Tm
for the CD38 C allele was 54.2◦C and 61.5◦C for the A allele.
Tm for the COMT val allele was 59.00◦C and 64.50◦C for the
met allele.
RESULTS
fMRI RESULTS
As already reported in Sauer et al. (2012), the comparison of social
to control stimuli led to a largely spread cortical and sub-cortical
brain activation (Figure 1). As expected, we found a strong acti-
vation of the bilateral amygdala (left amygdala: cluster-size = 132
voxels, peak voxel (x = −22, y = −5, z = −20): T(53) = 12.68,
FIGURE 1 | Brain activation to social stimuli compared to non-social
stimuli. (p < 0.05, family wise error corrected for the whole brain).
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pFWE < 0.001; right amygdala: cluster-size = 202 voxels, peak
voxel (x = 26, y = 1, z = −26): T(53) = 17.57, pFWE < 0.001).
ROI analyses of VTA and ventral striatum revealed no sig-
nificant results, neither for the single SNPs, nor for their
interaction. Regarding fusiform gyrus activation, we found no
significant results in addition to those already reported in
Sauer et al. (2012).
Analyses of amygdala activation revealed no gene main effect,
neither for CD38 nor for COMT. Furthermore, there was no sub-
stance main effect and no gene × substance interaction for any
variant. However, we found a significant gene× gene× substance
interaction (Figure 2A) in the bilateral amygdala (left amygdala:
cluster-size = 42 voxels, peak voxel (x = −18, y = −1, z = −12):
T(50) = 3.54, pFWE(ROI) = 0.01; right amygdala: cluster-size =
21 voxels, peak voxel (x = 20, y = −1, z = −10): T(50) = 3.25,
pFWE(ROI) < 0.05). This interaction is exclusively driven by a sig-
nificant gene× gene interaction occurring under PLA (Figure 2B;
left amygdala: cluster-size = 25 voxels, peak voxel (x = −14,
y = −3, z = −12): T(50) = 3.8, pFWE(ROI) < 0.01; right amyg-
dala: cluster-size = 23 voxels, peak voxel (x = 18, y = −1, z =
−15): T(50) = 3.68, pFWE(ROI) < 0.01).
Our analyses on the extracted data from the peak voxel sphere
replicated the three-way interaction between substance and the
two genotype groups on both sides (left amygdala: F(2/48) =
5.42, p < 0.01; right amygdala: F(2/48) = 4.53, p < 0.02). As dis-
played in Figure 3, there was a strong modulation of the effect
of CD38 on bilateral amygdala activation to social stimuli by
the COMT genotype. While A+ carriers showed strongest amyg-
dala activation when they were homozygote val allele carriers
and lowest activation when they were homozygote met allele
FIGURE 2 | Epistasis effect between CD38 and COMT in the amygdala.
(A) Voxel showing a significant three-way interaction between CD38,
COMT, and substance. (B) Interaction between CD38 and COMT for the
placebo condition. (p < 0.05, FWE corrected for the region of interest).
carriers, the opposite pattern was observed for A− carriers. In
contrast, under OT this epistasis effect was completely dimin-
ished resulting in no differences between the different genotype
configurations.
In addition, the GLM revealed a significant substance effect
for the left amygdala [F(1/48) = 14.02, p < 0.001). As can be seen
from Figure 3, and as reported before (e.g., Kirsch et al., 2005),
the activation in the left amygdala was reduced under OT when
compared to PLA. However, this effect was not observed for the
right amygdala whichmight be due to a significant valence× sub-
stance interaction reflecting that the OT attenuation effect was
only present for the negative but not the positive valent stim-
uli [left amygdala: F(1/48) = 19.59, p < 0.001; right amygdala:
F(1/48) = 5.31, p < 0.05, see Figure 4].
BEHAVIORAL RESULTS
Analysis of the RTs revealed a significant valence main effect
[F(1/48) = 7.53, p < 0.01] with reduced RTs during negative
when compared to positive stimuli. In addition we found a sig-
nificant substance × CD38 interaction [F(1/48) = 4.73, p < 0.05]
reflecting reduced RTs under OT specifically in the A− group.
This effect was already reported in our previous publication
(Sauer et al., 2012).
DISCUSSION
In the present study, we used an exploratory approach to test for
OT and DA associated gene effects and gene × gene interactions
on brain response to social stimuli as well as the modulation of
this response by OT. First of all, as already reported in Sauer et al.
(2012), presenting social stimuli of positive and negative valence
activated the bilateral amygdala allowing us to test for genetic
effects on this phenotype. Furthermore, at least with respect to
the analysis on the extracted sphere data, we replicated the often
shown amygdala dampening effect of OT. Interestingly, in con-
trast to other reports (Domes et al., 2007) the amygdala inhibition
in the present study was exclusively observed during negative
valent stimuli (Figure 4) supporting the idea of an anxiety or
social stress reducing effect of OT.
Regarding our main focus on the four different brain regions,
we found neither effects of the single genotypes nor interaction
effects on the VTA or the ventral striatum. At first glance, this is
in contrast to the reported animal literature which showed strong
evidence for an OT-DA interaction in these mesolimbic struc-
tures. However, there are aspects which could be responsible for
our negative findings. First, most of the animal research focuses
on OT-DA interactions in the context of sexual behavior which
probably leads to a stronger activation of the endogenous OT and
DA systems than our fMRI task. One could hypothesize that inter-
action effects in mesolimbic structures like the VTA or the ventral
striatum can only be seen in a condition of sexual arousal. Second,
the fMRI task we used neither robustly activates the VTA nor the
ventral striatum which is a clear drawback for the identification of
subtle gene effect. In a future study one should test this hypoth-
esis using an appropriate fMRI task to address these mesolimbic
structures.
No additional effect could be found for the fusiform gyrus,
either. Therefore, the effect of CD38 genotype on fusiform
www.frontiersin.org April 2013 | Volume 7 | Article 45 | 5
Sauer et al. Oxytocin × dopamine interactions
FIGURE 3 | Mean contrast estimates for the region of interest
(amygdala peak voxel from the SPM model + 5mm sphere) for the
contrast “social > non-social” in the left and right amygdala
reflecting the three-way interaction between CD38, COMT, and the
substance. While there is a clear interaction between the investigated
genetic variants in the placebo condition (upper panels), this interaction
disappears for the oxytocin condition (lower panels). (+p < 0.1,
∗p < 0.05).
FIGURE 4 | Mean contrast estimates for the different valence conditions and the two substances reflecting the significant interaction between
valence and substance (∗p < 0.05).
activation (Sauer et al., 2012) is obviously independent of COMT
val158met polymorphism. However, it could still be influenced
by other genetic variants. This remains to be investigated in the
future.
Regarding amygdala activation, we found no single gene effects
but strong evidence for an epistasis effect of both genes reflect-
ing an interaction between the OT and the DA system in the
response to socially relevant stimuli. The effect of central OT
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secretion, as indexed by CD38 rs3796863 genotype, was strongly
influenced by the COMT rs4860 genotype (Figures 2, 3). While
increased OT secretion (CD38 rs3796863 A+ group) attenu-
ated amygdala responses to socially relevant stimuli under the
high DA condition (homozygote COMT rs4860 met allele carri-
ers), it was facilitated under the low DA condition (homozygote
COMT rs4860 val allele carriers). Furthermore, since there was
no difference between the A+ and the A− group in COMT
val158met heterozygotes, the results support the existence of a
COMT gene dose effect on the CD38 modulated amygdala acti-
vation. Taking it the other way around, the effect of COMT
val158met genotype on amygdala activation is strongly depend-
ing on central OT secretion. This could explain the heterogeneity
of imaging genetics studies on COMT and amygdala activation
ranging from increased activation in met allele carriers (e.g.,
Smolka et al., 2005; Rasch et al., 2010; Lonsdorf et al., 2011)
to higher activation in val allele carriers (e.g., Domschke et al.,
2008; Lelli-Chiesa et al., 2011). As long as OT system activ-
ity and sensitivity is not controlled, sample stratification effects
might strongly influence the effect of the COMT genotype. The
study by Domschke and colleagues (2008) for example investi-
gated patients with panic disorder. Since anxiety disorders have
been associated with oxytocin system alterations (Opacka-Juffry
and Mohiyeddini, 2012), it could be speculated that the COMT
effects are related to OT system specificities in these patients.
However, it has to be emphasized that these relations between
anxiety and OT are sex specific (Weisman et al., 2012) but the
study by Domschke and colleagues investigated a mixed sample.
Another example where the interaction of DA and OT could be
important is the study by Lelli-Chiesa and colleagues (2011). They
investigated a sample of patients with bipolar disorder and found
reduced amygdala activation in met allele carriers. Interestingly, it
has been known for a longer time that mood disorders, particu-
larly depression, are associated with OT system alterations (Purba
et al., 1996) and it has been shown recently for depressed uni-
and bi-polar patients to have reduced OT serum levels (Ozsoy
et al., 2009). Therefore, alterations in the patient’s OT system
could have influenced the COMT effect reported by Lelli-Chiesa
and colleagues (2011). Interestingly, there is also a report of a
slight association between the COMT met158 allele and teacher
rated anxiety in autistic students (Gadow et al., 2009) which
nicely fits to our finding of an increased amygdala activation
in CD38 risk allele carriers also carrying the COMT met158
allele.
Our results could also be explained in the context of the
warrior/worrier model (Goldman et al., 2005). Since homozy-
gote met allele carriers (worriers) are more sensitive to stressors
and have a higher trait anxiety (Stein et al., 2005), they might
particularly benefit from an increased OT level as present in
the A+ carriers of the CD38 gene leading to the well-known
stress dampening effect of OT on the amygdala. This might
be reflected in the reduced amygdala activation to social stim-
uli in metmet/A+ individuals compared to metmet/A− indi-
viduals. In contrast homozygote val allele carriers (warriors)
might be less sensitive to social stimuli as has been shown
for faces (Drabant et al., 2006) which might be modulated
by OT. In this case, increased OT (CD38 A+ carriers) could
enhance the salience of social stimuli or socially relevant aspects
of a picture like the eyes (Guastella et al., 2008) which then
might increase amygdala response (Gamer and Buchel, 2009)
as seen for the valval/A+ carriers compared to the valval/A−
carriers.
However, this epistasis effect was exclusively present for the
PLA condition while the application of intranasal OT com-
pletely diminished the observed interaction (Figure 3). It could
be assumed that the presence of exogenous OT eliminates the
subtle effects of differential endogenous OT secretion related to
the genetic variant in CD38. While CD38 has been found to be
relevant for the auto regulation of OT secretion, particularly dur-
ing the administration of exogenous OT (Lopatina et al., 2010),
the differences between CD38 genotypes might be less relevant
when exogenous OT strongly influences this pathway. Therefore,
since we found no effect of genetic variants after OT application,
neither the CD38 nor the COMT genotype seem to substantially
impact the pharmacologic effect of OT.
In general, when interpreting the results, we have to take into
account that the direct biological pathways underlying are not
clear. CD38 is not specific for the OT system and the effect could
theoretically be due to other effects of CD38 like its impact on
insulin secretion (Kim et al., 2008). However, both the specificity
regarding neurotransmitter secretion in the brain (Jin et al., 2007)
as well as the fact that the CD38 gene effect observed here was
strongly diminished by OT administration supports the assump-
tion that our results are related to the OT specific effect of CD38.
Regarding COMT it has to be taken into account, that the enzyme
is mainly expressed on cortical sites (Matsumoto et al., 2003)
suggesting an indirect influence via a top-down modulation of
amygdala regions.
One major shortcoming of our study is the low number of
subjects in the extreme groups. This is mainly due to the fact,
that group assignment was performed post-hoc according to sub-
jects’ genotype. Therefore, replication of our results is definitely
needed. Nevertheless, our results are an interesting starting point
for future research leading toward a better understanding of
OT-DA interactions in humans. For example, it would be inter-
esting to see how this epistasis effect reacts to other intentional
changes of the OT-DA system, e.g., inhibition of DA signaling via
neuroleptic drugs.
Taken together, to our knowledge this is one of the first studies
demonstrating an OT × DA interaction in humans. While such
interactions have been shown in animal models, mainly in the
context of sexual and pair bonding behavior and in regions of the
mesolimbic DA system (Baskerville and Douglas, 2008), we could
demonstrate that they might also be relevant for a very important
basic process underlying human social functioning: the process-
ing of socially relevant stimuli and in a core structure of the limbic
system, the amygdala. Although the biological underpinnings of
the observed interaction have still to be elucidated, it could be
argued that for a substantial understanding of the effect of social
hormones on the social brain and human social behavior, inter-
actions with other transmitter systems like the DA system have to
be taken into account.
www.frontiersin.org April 2013 | Volume 7 | Article 45 | 7
Sauer et al. Oxytocin × dopamine interactions
ACKNOWLEDGMENTS
This research was supported by a research grant from
the Deutsche Forschungsgemeinschaft (German Research
Association, DFG) to Peter Kirsch (KI 576/10-1) and Martin
Reuter (RE 1692/4-1). We thank Christiane Wörner, André
Spachmann and Dagmar Gass for their support during data
acquisition and analysis. The research reported here was
conducted in the absence of any commercial or financial rela-
tionships that could be construed as a potential conflict of
interest.
REFERENCES
Baskerville, T. A., Allard, J., Wayman,
C., and Douglas, A. J. (2009).
Dopamine-oxytocin interactions in
penile erection. Eur. J. Neurosci. 30,
2151–2164.
Baskerville, T. A., and Douglas, A.
J. (2008). Interactions between
dopamine and oxytocin in the
control of sexual behaviour. Prog.
Brain Res. 170, 277–290.
Baumgartner, T., Heinrichs, M.,
Vonlanthen, A., Fischbacher, U.,
and Fehr, E. (2008). Oxytocin
shapes the neural circuitry of trust
and trust adaptation in humans.
Neuron 58, 639–650.
Born, J., Lange, T., Kern, W., McGregor,
G. P., Bickel, U., and Fehm, H.
L. (2002). Sniffing neuropep-
tides: a transnasal approach to the
human brain. Nat. Neurosci. 5,
514–516.
Buckert, M., Kudielka, B. M., Reuter,
M., and Fiebach, C. J. (2012). The
COMT Val158Met polymorphism
modulates working memory perfor-
mance under acute stress. Psychone
uroendocrinology 37, 1810–1821.
Chen, J., Lipska, B. K., Halim, N., Ma,
Q. D., Matsumoto, M., Melhem, S.,
et al. (2004). Functional analysis
of genetic variation in catechol-
O-methyltransferase (COMT):
effects on mRNA, protein, and
enzyme activity in postmortem
human brain. Am. J. Hum. Genet.
75, 807–821.
Domes, G., Heinrichs, M., Glascher,
J., Buchel, C., Braus, D. F., and
Herpertz, S. C. (2007). Oxytocin
attenuates amygdala responses
to emotional faces regardless
of valence. Biol. Psychiatry 62,
1187–1190.
Domschke, K., Baune, B. T., Havlik,
L., Stuhrmann, A., Suslow, T.,
Kugel, H., et al. (2012). Catechol-
O-methyltransferase gene variation:
impact on amygdala response to
aversive stimuli. Neuroimage 60,
2222–2229.
Domschke, K., Ohrmann, P., Braun,
M., Suslow, T., Bauer, J., Hohoff,
C., et al. (2008). Influence of
the catechol-O-methyltransferase
val158met genotype on amygdala
and prefrontal cortex emotional
processing in panic disorder.
Psychiatry Res. 163, 13–20.
Drabant, E. M., Hariri, A. R., Meyer-
Lindenberg, A., Munoz, K. E.,
Mattay, V. S., Kolachana, B.
S., et al. (2006). Catechol O-
methyltransferase val158met
genotype and neural mechanisms
related to affective arousal and
regulation. Arch. Gen. Psychiatry 63,
1396–1406.
Ekman, P., and Friesen, W. V. (1976).
Pictures of Facial Affect. Palo Alto,
CA: Consulting Psychologists Press.
Feldman, R., Zagoory-Sharon, O.,
Weisman, O., Schneiderman, I.,
Gordon, I., Maoz, R., et al. (2012).
Sensitive parenting is associated
with plasma oxytocin and poly-
morphisms in the OXTR and CD38
genes. Biol. Psychiatry 72, 175–181.
Gadow, K. D., Roohi, J., Devincent,
C. J., Kirsch, S., and Hatchwell,
E. (2009). Association of COMT
(Val158Met) and BDNF (Val66Met)
gene polymorphisms with anxiety,
ADHD and tics in children with
autism spectrum disorder. J. Autism
Dev. Disord. 39, 1542–1551.
Gamer, M., and Buchel, C. (2009).
Amygdala activation predicts gaze
toward fearful eyes. J. Neurosci. 29,
9123–9126.
Goldman, D., Oroszi, G., and Ducci,
F. (2005). The genetics of addic-
tions: uncovering the genes. Nat.
Rev. Genet. 6, 521–532.
Guarraci, F. A., Frohardt, R. J., and
Kapp, B. S. (1999). Amygdaloid D1
dopamine receptor involvement in
Pavlovian fear conditioning. Brain
Res. 827, 28–40.
Guastella, A. J., Mitchell, P. B., and
Dadds, M. R. (2008). Oxytocin
increases gaze to the eye region of
human faces. Biol. Psychiatry 63,
3–5.
Hariri, A. R., Mattay, V. S., Tessitore,
A., Fera, F., Smith, W. G., and
Weinberger, D. R. (2002a).
Dextroamphetamine modulates
the response of the human amyg-
dala. Neuropsychopharmacology 27,
1036–1040.
Hariri, A. R., Tessitore, A., Mattay, V.
S., Fera, F., and Weinberger, D. R.
(2002b). The amygdala response to
emotional stimuli: a comparison of
faces and scenes. Neuroimage 17,
317–323.
Hariri, A. R., Mattay, V. S., Tessitore,
A., Fera, F., and Weinberger, D.
R. (2003). Neocortical modulation
of the amygdala response to fear-
ful stimuli. Biol. Psychiatry 53,
494–501.
Insel, T. R., and Shapiro, L. E. (1992).
Oxytocin receptor distribution
reflects social organization in
monogamous and polygamous
voles. Proc. Natl. Acad. Sci. U.S.A.
89, 5981–5985.
Jin, D., Liu, H. X., Hirai, H., Torashima,
T., Nagai, T., Lopatina, O., et al.
(2007). CD38 is critical for social
behaviour by regulating oxytocin
secretion. Nature 446, 41–45.
Kempton, M. J., Haldane, M., Jogia,
J., Christodoulou, T., Powell, J.,
Collier, D., et al. (2009). The effects
of gender and COMT Val158Met
polymorphism on fearful facial
affect recognition: a fMRI study.
Int. J. Neuropsychopharmacol. 12,
371–381.
Kienast, T., Hariri, A. R., Schlagenhauf,
F., Wrase, J., Sterzer, P., Buchholz,
H. G., et al. (2008). Dopamine in
amygdala gates limbic processing of
aversive stimuli in humans. Nat.
Neurosci. 11, 1381–1382.
Kim, B. J., Park, K. H., Yim, C. Y.,
Takasawa, S., Okamoto, H., Im,
M. J., et al. (2008). Generation of
nicotinic acid adenine dinucleotide
phosphate and cyclic ADP-ribose
by glucagon-like peptide-1 evokes
Ca2+ signal that is essential for
insulin secretion in mouse pancre-
atic islets. Diabetes 57, 868–878.
Kirsch, P., Esslinger, C., Chen, Q., Mier,
D., Lis, S., Siddhanti, S., et al.
(2005). Oxytocin modulates neural
circuitry for social cognition and
fear in humans. J. Neurosci. 25,
11489–11493.
Lang, P. J., Bradley, M. M.,
and Cuthbert, B. N. (2008).
International Affective Picture
System (IAPS): Affective Ratings of
Pictures and Instruction Manual.
Technical Report A-8. Gainesville,
FL: University of Florida.
Lelli-Chiesa, G., Kempton, M. J.,
Jogia, J., Tatarelli, R., Girardi,
P., Powell, J., et al. (2011). The
impact of the Val158Met catechol-
O-methyltransferase genotype on
neural correlates of sad facial affect
processing in patients with bipolar
disorder and their relatives. Psychol.
Med. 41, 779–788.
Lerer, E., Levi, S., Israel, S., Yaari,
M., Nemanov, L., Mankuta, D.,
et al. (2010). Low CD38 expres-
sion in lymphoblastoid cells and
haplotypes are both associated with
autism in a family-based study.
Autism Res. 3, 293–302.
Liu, Y., and Wang, Z. X. (2003).
Nucleus accumbens oxytocin and
dopamine interact to regulate pair
bond formation in female prairie
voles. Neuroscience 121, 537–544.
Lonsdorf, T. B., Golkar, A., Lindstom,
K. M., Fransson, P., Schalling,
M., Ohman, A., et al. (2011).
5-HTTLPR and COMTval158met
genotype gate amygdala reactivity
and habituation. Biol. Psychol. 87,
106–112.
Lopatina, O., Liu, H. X., Amina, S.,
Hashii, M., and Higashida, H.
(2010). Oxytocin-induced ele-
vation of ADP-ribosyl cyclase
activity, cyclic ADP-ribose or
Ca(2+) concentrations is involved
in autoregulation of oxytocin
secretion in the hypothalamus
and posterior pituitary in male
mice. Neuropharmacology 58,
50–55.
Love, T. M., Enoch, M. A., Hodgkinson,
C. A., Pecina, M., Mickey, B.,
Koeppe, R. A., et al. (2012).
Oxytocin gene polymorphisms
influence human dopaminer-
gic function in a sex-dependent
manner. Biol. Psychiatry 72,
198–206.
Matsumoto, M., Weickert, C. S., Akil,
M., Lipska, B. K., Hyde, T. M.,
Herman, M. M., et al. (2003). Cat
echol O-methyltransferase mRNA
expression in human and rat brain:
evidence for a role in cortical neu-
ronal function. Neuroscience 116,
127–137.
Melis, M. R., Melis, T., Cocco, C.,
Succu, S., Sanna, F., Pillolla, G.,
et al. (2007). Oxytocin injected into
the ventral tegmental area induces
penile erection and increases extra-
cellular dopamine in the nucleus
accumbens and paraventricular
nucleus of the hypothalamus of
male rats. Eur. J. Neurosci. 26,
1026–1035.
Melis, M. R., Succu, S., Sanna, F.,
Boi, A., and Argiolas, A. (2009).
Oxytocin injected into the ventral
subiculum or the posteromedial
Frontiers in Neuroscience | Neuroendocrine Science April 2013 | Volume 7 | Article 45 | 8
Sauer et al. Oxytocin × dopamine interactions
cortical nucleus of the amyg-
dala induces penile erection and
increases extracellular dopamine
levels in the nucleus accumbens
of male rats. Eur. J. Neurosci. 30,
1349–1357.
Meyer-Lindenberg, A., Domes, G.,
Kirsch, P., and Heinrichs, M.
(2011). Oxytocin and vasopressin in
the human brain: social neuropep-
tides for translational medicine.
Nat. Rev. Neurosci. 12, 524–538.
Mier, D., Kirsch, P., and Meyer-
Lindenberg, A. (2010). Neural
substrates of pleiotropic action
of genetic variation in COMT: a
meta-analysis. Mol. Psychiatry 15,
918–927.
Munesue, T., Yokoyama, S., Nakamura,
K., Anitha, A., Yamada, K., Hayashi,
K., et al. (2010). Two genetic vari-
ants of CD38 in subjects with
autism spectrum disorder and con-
trols. Neurosci. Res. 67, 181–191.
Naylor, J. C., Li, Q., Kang-Park, M.
H., Wilson, W. A., Kuhn, C., and
Moore, S. D. (2010). Dopamine
attenuates evoked inhibitory synap-
tic currents in central amygdala
neurons. Eur. J. Neurosci. 32,
1836–1842.
Opacka-Juffry, J., and Mohiyeddini,
C. (2012). Experience of stress in
childhood negatively correlates with
plasma oxytocin concentration in
adult men. Stress 15, 1–10.
Ozsoy, S., Esel, E., and Kula, M. (2009).
Serum oxytocin levels in patients
with depression and the effects of
gender and antidepressant treat-
ment. Psychiatry Res. 169, 249–252.
Petrovic, P., Kalisch, R., Singer, T., and
Dolan, R. J. (2008). Oxytocin atten-
uates affective evaluations of condi-
tioned faces and amygdala activity.
J. Neurosci. 28, 6607–6615.
Purba, J. S., Hoogendijk, W. J., Hofman,
M. A., and Swaab, D. F. (1996).
Increased number of vasopressin-
and oxytocin-expressing neurons
in the paraventricular nucleus
of the hypothalamus in depres-
sion. Arch. Gen. Psychiatry 53,
137–143.
Rasch, B., Spalek, K., Buholzer, S.,
Luechinger, R., Boesiger, P., De
Quervain, D. J., et al. (2010).
Aversive stimuli lead to differ-
ential amygdala activation and
connectivity patterns depending
on catechol-O-methyltransferase
Val158Met genotype. Neuroimage
52, 1712–1719.
Romero-Fernandez, W., Borroto-
Escuela, D. O., Agnati, L. F., and
Fuxe, K. (2012). Evidence for
the existence of dopamine d2-
oxytocin receptor heteromers in
the ventral and dorsal striatum
with facilitatory receptor-receptor
interactions. Mol. Psychiatry. doi:
10.1038/mp.2012.103. [Epub ahead
of print].
Sauer, C., Montag, C., Worner, C.,
Kirsch, P., and Reuter, M. (2012).
Effects of a common variant in
the CD38 gene on social pro-
cessing in an oxytocin challenge
study: possible links to autism.
Neuropsychopharmacology 37,
1474–1482.
Skuse, D. H., and Gallagher, L. (2009).
Dopaminergic-neuropeptide inter-
actions in the social brain. Trends
Cogn. Sci. 13, 27–35.
Smolka, M. N., Buhler, M., Schumann,
G., Klein, S., Hu, X. Z., Moayer,
M., et al. (2007). Gene-gene effects
on central processing of aver-
sive stimuli. Mol. Psychiatry 12,
307–317.
Smolka, M. N., Schumann, G., Wrase,
J., Grusser, S. M., Flor, H., Mann,
K., et al. (2005). Catechol-O-
methyltransferase val158met
genotype affects processing of
emotional stimuli in the amygdala
and prefrontal cortex. J. Neurosci.
25, 836–842.
Stein, M. B., Fallin, M. D., Schork, N.
J., and Gelernter, J. (2005). COMT
polymorphisms and anxiety-related
personality traits. Neuropsycho
pharmacology 30, 2092–2102.
Tessitore, A., Hariri, A. R., Fera, F.,
Smith, W. G., Chase, T. N., Hyde,
T. M., et al. (2002). Dopamine
modulates the response of the
human amygdala: a study in
Parkinson’s disease. J. Neurosci. 22,
9099–9103.
Walter, B., Blecker, C., Kirsch, P.,
Sammer, G., Schienle, A., Stark, R.,
et al. (2003). MARINA: an easy to
use tool for the creation of MAsks
for Region of INterest Analyses
[abstract]. Neuroimage 19. Available
on CD.
Weisman, O., Zagoory-Sharon, O.,
Schneiderman, I., Gordon,
I., and Feldman, R. (2012).
Plasma oxytocin distributions
in a large cohort of women
and men and their gender-
specific associations with anxiety.
Psychoneuroendocrinology. doi:
10.1016/j.psyneuen.2012.08.011.
[Epub ahead of print].
Williams, L. M., Gatt, J. M., Grieve, S.
M., Dobson-Stone, C., Paul, R. H.,
Gordon, E., et al. (2010). COMT
Val (108/158)Met polymorphism
effects on emotional brain function
and negativity bias. Neuroimage 53,
918–925.
Yamasue, H., Yee, J. R., Hurlemann,
R., Rilling, J. K., Chen, F. S.,
Meyer-Lindenberg, A., et al. (2012).
Integrative approaches utilizing
oxytocin to enhance prosocial
behavior: from animal and human
social behavior to autistic social
dysfunction. J. Neurosci. 32,
14109–14117.
Young, L. J., and Wang, Z. (2004). The
neurobiology of pair bonding. Nat.
Neurosci. 7, 1048–1054.
Zink, C. F., and Meyer-Lindenberg,
A. (2012). Human neuroimaging
of oxytocin and vasopressin in
social cognition. Horm. Behav. 61,
400–409.
Zubieta, J. K., Heitzeg, M. M., Smith,
Y. R., Bueller, J. A., Xu, K., Xu, Y.,
et al. (2003). COMT val158met
genotype affects mu-opioid
neurotransmitter responses to
a pain stressor. Science 299,
1240–1243.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 14 December 2012; paper
pending published: 09 January 2013;
accepted: 12 March 2013; published
online: 01 April 2013.
Citation: Sauer C, Montag C, Reuter
M and Kirsch P (2013) Imaging oxy-
tocin × dopamine interactions: an epis-
tasis effect of CD38 and COMT gene
variants influences the impact of oxytocin
on amygdala activation to social stimuli.
Front. Neurosci. 7:45. doi: 10.3389/fnins.
2013.00045
This article was submitted to Frontiers
in Neuroendocrine Science, a specialty of
Frontiers in Neuroscience.
Copyright © 2013 Sauer, Montag,
Reuter and Kirsch. This is an open-
access article distributed under the terms
of the Creative Commons Attribution
License, which permits use, distribution
and reproduction in other forums, pro-
vided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
www.frontiersin.org April 2013 | Volume 7 | Article 45 | 9
